Login / Signup

A Single-Center Experience with Dupilumab for Atopic or Psoriasiform Dermatitis in Patients with Inflammatory Bowel Disease.

Elizabeth A SpencerMichael T DolingerMarla C Dubinsky
Published in: Digestive diseases and sciences (2022)
Dupilumab is safe and effective for dermatitis in patients with IBD, both primary atopic dermatitis and dermatitis induced or worsened by anti-TNF.
Keyphrases
  • atopic dermatitis
  • patients with inflammatory bowel disease
  • high glucose
  • diabetic rats
  • oxidative stress
  • endothelial cells
  • stress induced